357 related articles for article (PubMed ID: 17392553)
1. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
5. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
7. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
11. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes.
Hamaguchi K; Kimura A; Kusuda Y; Yamashita T; Yasunami M; Takahasi M; Abe N; Yoshimatsu H
Diabetes Res Clin Pract; 2004 Nov; 66(2):163-71. PubMed ID: 15533584
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
14. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity among patients with latent autoimmune diabetes in adults.
Maruyama T; Nakagawa T; Kasuga A; Murata M
Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
[TBL] [Abstract][Full Text] [Related]
16. [Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers].
Li X; Zhou ZG; Huang G; Yan X; Yang L; Hu BY
Zhonghua Nei Ke Za Zhi; 2003 Jan; 42(1):7-10. PubMed ID: 12757655
[TBL] [Abstract][Full Text] [Related]
17. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
18. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
[TBL] [Abstract][Full Text] [Related]
19. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
20. [Latent autoimmune (type 1) diabetes mellitus in patients originally classified as type 2. Divergence of etiologic markers].
Martinka E; Straková J; Galajda P; Shawkatová I; Buc M
Cas Lek Cesk; 2000 Mar; 139(4):120-3. PubMed ID: 10838742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
